<DOC>
	<DOCNO>NCT02917798</DOCNO>
	<brief_summary>This study evaluate patient ' experience gynecologic prostate medical oncologist surgeon offer genetic testing , genetic counselor return test result patient telephone . This different usual approach genetic testing , gynecologic prostate medical oncologist surgeon refer patient genetic counselor order test do , genetic counselor return test result patient person telephone . The investigator evaluate alternative way provide genetic test ovarian prostate cancer patient .</brief_summary>
	<brief_title>Streamlining Delivery Genetic Testing Ovarian Cancer Context : A Pilot Study Patient Outcomes</brief_title>
	<detailed_description />
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<criteria>MSK patient age 18 year old . Diagnosed invasive epithelial ovarian cancer , peritoneal cancer , fallopian tube cancer , prostate cancer . Deemed clinically appropriate multiplex genetic test MSK Gyn DMT GU DMT physician . Agreed receive clinical multiplex genetic test MSK Gyn DMT GU DMT physician . Englishfluent ; survey design validated English currently available language . Translation questionnaire language would require reestablish reliability validity measure . Therefore , participant must able communicate English complete survey . Patients receive ongoing cancer care MSK . Major psychiatric illness cognitive impairment judgment study investigator study staff would preclude study participation . Any patient unable comply study procedure determine study investigator study staff . For ovarian cancer patient : patient insure payer provide coverage multiplex genetic testing deliver protocol ( e.g. , Cigna , United Health Care , Oxford , ( payer require genetic counseling genetics professional prior test ) .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Genetic Testing</keyword>
	<keyword>16-919</keyword>
</DOC>